Quantcast
Last updated on April 23, 2014 at 16:13 EDT

Latest Prodrugs Stories

Genetic Markers May Signify Response To Breast Cancer Therapy
2013-06-13 19:09:12

Brett Smith for redOrbit.com — Your Universe Online New research from the Mayo Clinic has identified favorable genetic variations that increase the chances of a positive response to preventive breast cancer therapy with the drugs tamoxifen and raloxifene, according to a new report in the journal Cancer Discovery. "Our findings are important because we identified genetic factors that could eventually be used to select women who should be offered the drugs for prevention,"...

2013-06-13 08:28:04

NESS ZIONA, Israel, June 13, 2013 /PRNewswire/ -- NeuroDerm, Ltd. today announced that abstracts reporting results from a phase I study in healthy volunteers, and preliminary results from a phase IIA study in advanced Parkinson's patients, of ND0612, have been selected for presentation at the 17th International Congress of Parkinson's Disease and Movement Disorders, June 16th-20th in Sydney, Australia. ND0612 is a proprietary levodopa/carbidopa liquid drug formula under...

2013-06-06 23:18:53

Prescription drugs are so addictive that when teens begin to abuse them, they can quickly spiral into high levels of abuse and addiction. Parents often need help to know how to start fighting this trend. (PRWEB) June 06, 2013 According to the Partnership at Drugfree.org, there are more teens misusing and abusing prescription drugs than ever before. In April 2013, this non-profit organization published their annual Partnership Attitude Tracking Survey (PATS) that showed that one in four...

2013-06-06 18:31:08

The CatSalut protocol implies the immediate transfer of a patient who suffers a heart attack to a center with hemodynamic unit The Cardiovascular Research Laboratory of the IDIBELL led by the cardiologist of the Bellvitge University Hospital José Luis Ferreiro has conducted a study on the effect of antiplatelet drugs given to high risk patients suffering from acute myocardial infaction (heart attack) in the context of the Infarction Code. The study concludes that when...

Tamoxifen Can Halve Breast Cancer Risk When Prescribed Longer
2013-06-03 13:09:55

Lee Rannals for redOrbit.com — Your Universe Online Researchers announced new findings that taking one breast cancer drug for twice the time suggested can substantially increase survival rates. The scientists said that women diagnosed with breast cancer who take tamoxifen for 10 years, rather than five years, halve their chances of dying. "These findings are extremely exciting for women who are diagnosed with the most common type of breast cancer," said Dr Julia Wilson,...

2013-05-17 08:23:04

PITTSBURGH, May 17, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is the generic version of Abbvie Inc.'s Tricor(®) Tablets. Fenofibrate Tablets are indicated as adjunctive therapy to diet to reduce elevated...

2013-05-06 23:03:40

Studies conducted on the blood-thinning drug Plavix indicate no benefit when taken with aspirin and may increase changes of suffering a stroke. The Law Firm of d'Oliveira & Associates wishes to inform the general public that with Plavix going generic, cases of side effects associated with the drug may increase. (PRWEB) May 06, 2013 Marketed by Bristol-Myers Squibb and Sanofi Pharmaceuticals and currently the second most commonly prescribed drug on the U.S. market, Plavix is used to...

2013-04-25 19:46:09

Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study at Lund University in Sweden has found. Patients who took the pill, along with two or more cups of coffee daily, reported less than half the rate of cancer recurrence, compared with their non-coffee drinking, Tamoxifen-taking counterparts. The team followed over 600 breast cancer patients from southern Sweden for an average of five years. Approximately 300 took...

2013-04-23 18:47:52

Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to exploit tamoxifen´s secondary activities so that it might work on more aggressive breast cancer. The research, published in the journal EMBO Molecular Medicine, is a promising development for women with basal-like breast cancer, sometimes known as triple-negative disease. This subtype has a...

2013-03-26 20:22:33

WOODCLIFF LAKE, N.J., March 26, 2013 /PRNewswire/ -- Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved ACIPHEX(®) Sprinkle(TM) Delayed-Release Capsules 5mg and 10mg for the treatment of Gastroesophageal Reflux Disease (GERD) in children 1 to 11 years of age for up to 12 weeks. "We are proud to offer a new treatment option for young children who suffer from GERD," said Lonnel Coats, president and CEO of Eisai Inc. "Eisai is committed to keeping the...